Author Search Results :: Library Catalog

1

Transforming heart failure and cardio‐oncology care during COVID‐19 by Valentina Bracun, Rudolf A. deBoer

Published 2020-12-01

Get full text

Article

Save to List

Saved in:
2

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure by Jishnu Malgie, Jasper J. Brugts, Rudolf A. deBoer

Published 2023-09-01

Get full text

Article

Save to List

Saved in:
3

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease by Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer

Published 2020-01-01

Get full text

Article

Save to List

Saved in:
4

The role of immune checkpoints in cardiovascular disease by Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers

Published 2022-10-01

Get full text

Article

Save to List

Saved in:
5

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies by Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé

Published 2021-03-01

Get full text

Article

Save to List

Saved in:
6

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study by Rudolf A de Boer, Michiel Rienstra, Tom Wilsgaard, Maja-Lisa Løchen, Victor W Zwartkruis, Ekaterina Sharashova

Published 2022-08-01

Get full text

Article

Save to List

Saved in:
7

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? by Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, B. Daan Westenbrink

Published 2020-01-01

Get full text

Article

Save to List

Saved in:
8

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier by Edgar E. Nollet, B. Daan Westenbrink, Rudolf A. de Boer, Diederik W. D. Kuster, Jolanda van der Velden

Published 2020-11-01

Get full text

Article

Save to List

Saved in:
9

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population by Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé

Published 2021-04-01

Get full text

Article

Save to List

Saved in:
10

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis by Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri

Published 2020-09-01

Get full text

Article

Save to List

Saved in:
11

Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring. by Liza S M Wong, Jardi Huzen, Rudolf A de Boer, Wiek H van Gilst, Dirk J van Veldhuisen, Pim van der Harst

Published 2011-01-01

Get full text

Article

Save to List

Saved in:
12

The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro. by Bo Lu, Hasan Mahmud, Alexander H Maass, Bo Yu, Wiek H van Gilst, Rudolf A de Boer, Herman H W Silljé

Published 2010-01-01

Get full text

Article

Save to List

Saved in:
13

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes by Amy Groenewegen, Victor W. Zwartkruis, Betül Cekic, Rudolf. A. de Boer, Michiel Rienstra, Arno W. Hoes, Frans H. Rutten, Monika Hollander

Published 2021-06-01

Get full text

Article

Save to List

Saved in:
14

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation by Joylene E. Siland, Victor Zwartkruis, Bastiaan Geelhoed, Rudolf A. de Boer, Isabelle C. van Gelder, Pim van der Harst, Michiel Rienstra

Published 2020-04-01

Get full text

Article

Save to List

Saved in:
15

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure? by Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink

Published 2022-08-01

Get full text

Article

Save to List

Saved in:
16

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population by Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem

Published 2021-12-01

Get full text

Article

Save to List

Saved in:
17

The association of multimorbidity within cardio-metabolic disease domains with dietary patterns: A cross-sectional study in 129 369 men and women from the Lifelines cohort. by Louise H Dekker, Martin H de Borst, Laura M G Meems, Rudolf A de Boer, Stephan J L Bakker, Gerjan J Navis

Published 2019-01-01

Get full text

Article

Save to List

Saved in:
18

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C by Elles M. Screever, Jenny E. Kootstra-Ros, Joyce Doorn, Jellie A. Nieuwenhuis, Henk E. J. Meulenbelt, Wouter C. Meijers, Rudolf A. de Boer

Published 2021-09-01

Get full text

Article

Save to List

Saved in:
19

Evaluation of renal cancer progression in a mouse model of heart failure by Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer

Published 2021-08-01

Get full text

Article

Save to List

Saved in:
20

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population. by Lyanne M Kieneker, Michele F Eisenga, Michel M Joosten, Rudolf A de Boer, Ron T Gansevoort, Jenny E Kootstra-Ros, Gerjan Navis, Stephan J L Bakker

Published 2017-01-01

Get full text

Article

Save to List

Saved in:

Find in Library

Search Results - Rudolf A. de Boer

Transforming heart failure and cardio‐oncology care during COVID‐19 by Valentina Bracun, Rudolf A. deBoer

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure by Jishnu Malgie, Jasper J. Brugts, Rudolf A. deBoer

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease by Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer

The role of immune checkpoints in cardiovascular disease by Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies by Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study by Rudolf A de Boer, Michiel Rienstra, Tom Wilsgaard, Maja-Lisa Løchen, Victor W Zwartkruis, Ekaterina Sharashova

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? by Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, B. Daan Westenbrink

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier by Edgar E. Nollet, B. Daan Westenbrink, Rudolf A. de Boer, Diederik W. D. Kuster, Jolanda van der Velden

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population by Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis by Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri

Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring. by Liza S M Wong, Jardi Huzen, Rudolf A de Boer, Wiek H van Gilst, Dirk J van Veldhuisen, Pim van der Harst

The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro. by Bo Lu, Hasan Mahmud, Alexander H Maass, Bo Yu, Wiek H van Gilst, Rudolf A de Boer, Herman H W Silljé

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes by Amy Groenewegen, Victor W. Zwartkruis, Betül Cekic, Rudolf. A. de Boer, Michiel Rienstra, Arno W. Hoes, Frans H. Rutten, Monika Hollander

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation by Joylene E. Siland, Victor Zwartkruis, Bastiaan Geelhoed, Rudolf A. de Boer, Isabelle C. van Gelder, Pim van der Harst, Michiel Rienstra

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure? by Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population by Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem

The association of multimorbidity within cardio-metabolic disease domains with dietary patterns: A cross-sectional study in 129 369 men and women from the Lifelines cohort. by Louise H Dekker, Martin H de Borst, Laura M G Meems, Rudolf A de Boer, Stephan J L Bakker, Gerjan J Navis

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C by Elles M. Screever, Jenny E. Kootstra-Ros, Joyce Doorn, Jellie A. Nieuwenhuis, Henk E. J. Meulenbelt, Wouter C. Meijers, Rudolf A. de Boer

Evaluation of renal cancer progression in a mouse model of heart failure by Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population. by Lyanne M Kieneker, Michele F Eisenga, Michel M Joosten, Rudolf A de Boer, Ron T Gansevoort, Jenny E Kootstra-Ros, Gerjan Navis, Stephan J L Bakker

Search Tools: